BioRestorative Therapies (BRTX) EPS (Weighted Average and Diluted) (2019 - 2025)
Historic EPS (Weighted Average and Diluted) for BioRestorative Therapies (BRTX) over the last 7 years, with Q3 2025 value amounting to -$0.33.
- BioRestorative Therapies' EPS (Weighted Average and Diluted) fell 15384.62% to -$0.33 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.47, marking a year-over-year decrease of 279.72%. This contributed to the annual value of -$1.49 for FY2024, which is 5875.22% up from last year.
- Per BioRestorative Therapies' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.33 for Q3 2025, which was down 15384.62% from -$0.38 recorded in Q2 2025.
- BioRestorative Therapies' EPS (Weighted Average and Diluted)'s 5-year high stood at $0.39 during Q3 2023, with a 5-year trough of -$20.62 in Q1 2021.
- For the 5-year period, BioRestorative Therapies' EPS (Weighted Average and Diluted) averaged around -$2.27, with its median value being -$0.7 (2023).
- In the last 5 years, BioRestorative Therapies' EPS (Weighted Average and Diluted) plummeted by 152084852.92% in 2021 and then surged by 13062.31% in 2023.
- Quarter analysis of 5 years shows BioRestorative Therapies' EPS (Weighted Average and Diluted) stood at -$4.99 in 2021, then soared by 74.06% to -$1.29 in 2022, then surged by 41.0% to -$0.76 in 2023, then skyrocketed by 54.62% to -$0.35 in 2024, then grew by 4.76% to -$0.33 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.33 for Q3 2025, versus -$0.38 for Q2 2025 and -$0.64 for Q1 2025.